NMOSD

Clinical trials for NMOSD explained in plain language.

Never miss a new study

Get alerted when new NMOSD trials appear

Sign up with your email to follow new studies for NMOSD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Not yet finished but already full! 1

New hope for NMOSD patients: drug aims to slash relapse rate

Disease control Ongoing

This study tests eculizumab in 21 Chinese adults with a rare autoimmune disease called NMOSD, which causes attacks on the nervous system. Participants must have had at least one relapse in the past year. The goal is to see if the drug can reduce the number of relapses and slow di…

Matched conditions: NMOSD

Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 04, 2026 16:30 UTC

NMOSD

Get alerted when new NMOSD trials appear

New hope for NMOSD patients: drug aims to slash relapse rate